Apyx Medical Corporation (APYX)

$5.61

-0.25 (-4.27%)
Rating:
Recommendation:
-
Symbol APYX
Price $5.61
Beta 1.128
Volume Avg. 0.80M
Market Cap 193.394M
Shares () -
52 Week Range 3.01-17.5
1y Target Est -
DCF Unlevered APYX DCF ->
DCF Levered APYX LDCF ->
ROE -30.18% Strong Sell
ROA -25.79% Sell
Operating Margin -
Debt / Equity 26.54% Neutral
P/E -
P/B 3.90 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest APYX news


Mr. Charles Goodwin
Healthcare
Medical Devices
NASDAQ Global Select

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.